A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma

Conditions:   DLBCL;   Diffuse Large B Cell Lymphoma Interventions:   Drug: R-pola-mini-CHP;   Drug: R-mini-CHOP Sponsors:   Nordic Lymphoma Group;   Roche Pharma AG Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Lymphoma | Research